EGFR and familial pancreatic carcinoma: The importance of EGF-R signalling in promoting and maintaining pancreatic cancer growth is highlighted by studies showing decreased growth in mice treated with a receptor tyrosine kinase blocker [7] and by an EGF-R blocking antibody [8,9].